Personal Genome Diagnostics Inc. (PGDx), a pioneer in conducting patient-specific analyses aimed at identifying genomic alterations in tumors, today announced a number of developments that will support its expanding business. The company licensed exclusive rights to Digital Karyotyping (DK), an important genome-mapping technology developed by the company’s founders at Johns Hopkins University. PGDx also announced that it is expanding into new facilities and has made a number of key hires, including Genzyme Oncology executive Antony Newton as Chief Commercial Officer.
{iframe}http://www.prnewswire.com/news-releases/personal-genome-diagnostics-inc-licenses-genome-mapping-technology-from-johns-hopkins-university-and-expands-its-cancer-genome-analysis-business-195841591.html{/iframe}